Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Helldin

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Schizophrenia Research|September 4, 2007
Remission in schizophrenia: applying recent consensus criteria to refine the conceptRobert A Lasser, Henry Nasrallah, Lars Helldin, et al.
The International Journal of Neuropsychopharmacology|February 16, 2005
Pharmacokinetics and D2 receptor occupancy of long-acting injectable risperidone (Risperdal Consta) in patients with schizophreniaOla Gefvert, Bo Eriksson, Per Persson, et al.
Therapeutic Advances in Psychopharmacology|August 25, 2015
Treatment response, safety, and tolerability of paliperidone extended release treatment in patients recently diagnosed with schizophreniaLars Helldin, Joseph Peuskens, Roland Vauth, et al.
The American Journal of Psychiatry|June 3, 2009
Performance-based measurement of functional disability in schizophrenia: a cross-national study in the United States and SwedenPhilip D Harvey, Lars Helldin, Christopher R Bowie, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Schizophrenia Research|September 4, 2007
Remission in schizophrenia: applying recent consensus criteria to refine the conceptRobert A Lasser, Henry Nasrallah, Lars Helldin, et al.
The International Journal of Neuropsychopharmacology|February 16, 2005
Pharmacokinetics and D2 receptor occupancy of long-acting injectable risperidone (Risperdal Consta) in patients with schizophreniaOla Gefvert, Bo Eriksson, Per Persson, et al.
Therapeutic Advances in Psychopharmacology|August 25, 2015
Treatment response, safety, and tolerability of paliperidone extended release treatment in patients recently diagnosed with schizophreniaLars Helldin, Joseph Peuskens, Roland Vauth, et al.
The American Journal of Psychiatry|June 3, 2009
Performance-based measurement of functional disability in schizophrenia: a cross-national study in the United States and SwedenPhilip D Harvey, Lars Helldin, Christopher R Bowie, et al.
Pageof 4